Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks. As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property. Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews. Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues. The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding. Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC). The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review. Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review.

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Custom text		Organization Sort descending
Dec 14 2021	Non-Prosecution Agreement Announced in Underwriters Laboratories (UL) Chinese Criminal Copyright Case	Schwegman, Lundberg & Woessner, P.A.
Apr 5 2011	Factors in Deciding Motions to Stay Litigation Pending Reexamination	Schwegman, Lundberg & Woessner, P.A.
Feb 12 2022	China to Cease Issuing Paper Patent Certificates – Request Them Before March 1, 2022	Schwegman, Lundberg & Woessner, P.A.
Apr 25 2011	Petition Granted for Rehearing en banc of Akamai Technologies v. Limelight Networks	Schwegman, Lundberg & Woessner, P.A.
May 8 2011	What Were They Thinking? A Second Look at Lilly v. Sun	Schwegman, Lundberg & Woessner, P.A.
May 18 2011	Patent Office Broadens “First Action Interview” Pilot Program	Schwegman, Lundberg & Woessner, P.A.
Oct 6 2017	Federal Circuit’s Aqua Products Decision Clarifies Burden on IPR Petitioner to Challenge Amended Claims	Schwegman, Lundberg & Woessner, P.A.
Jul 11 2022	China’s National Intellectual Property Administration Registers China Manned Space Logo	Schwegman, Lundberg & Woessner, P.A.
Nov 1 2022	China’s National Intellectual Property Administration Releases New Draft of the Patent Examination Guidelines	Schwegman, Lundberg & Woessner, P.A.
Nov 6 2012	Voter Verified Decision Elaborates on Internet Publication	Schwegman, Lundberg & Woessner, P.A.
Mar 6 2023	China’s Supreme People’s Court Releases Report on the Judicial Reform of Chinese Courts (2013-2022)	Schwegman, Lundberg & Woessner, P.A.
Oct 16 2018	UCB, Inc. v. Accord Healthcare, Inc. – Can a Racemic Mixture be a “Lead Compound.”	Schwegman, Lundberg & Woessner, P.A.
May 22 2023	Supreme Court Voids Amgen’s Patents using “Undue Experimentation” Standard	Schwegman, Lundberg & Woessner, P.A.
May 28 2023	China’s National Intellectual Property Administration Releases “Guidelines for the Determination of Abnormal Patent Applications and the Handling of Matters after the Determination”	Schwegman, Lundberg & Woessner, P.A.
Mar 27 2013	Federal Court Affirms Board of Patent Appeals and Interferences (BPAI) in Dawson v. Dawson and Bowman	Schwegman, Lundberg & Woessner, P.A.
Apr 26 2013	Progressive Casualty Litigation Stayed Pending Outcome of Liberty Mutual Covered Business Method Patents	Schwegman, Lundberg & Woessner, P.A.
May 16 2013	CLS Bank v. Alice Corp. (Part 2) Re: Patent Litigation	Schwegman, Lundberg & Woessner, P.A.
Sep 1 2023	China’s National Intellectual Property Administration Releases Guidelines for Delayed Examination of Invention Patent Applications	Schwegman, Lundberg & Woessner, P.A.
Nov 2 2023	China’s Supreme People’s Court Adjusts Jurisdiction of their IP Tribunal	Schwegman, Lundberg & Woessner, P.A.
Nov 9 2023	China’s National Intellectual Property Administration Releases Guidelines on Subject Matter Eligibility of Utility Model Patents	Schwegman, Lundberg & Woessner, P.A.
Dec 10 2023	China Releases Second Batch of Warning Cases in ‘Blue Sky’ Special Rectification Program of the Patent Agent Industry	Schwegman, Lundberg & Woessner, P.A.
Nov 4 2013	Synthes v. Spinal Kinetics – When “Structure” is Not Enough Re: Patent Litigation	Schwegman, Lundberg & Woessner, P.A.
Jan 27 2024	China’s Supreme People’s Court Clarifies Conditions Needed to Prove Patent Infringement Lawsuit Filed in Bad Faith	Schwegman, Lundberg & Woessner, P.A.
Nov 11 2013	Ariosa Diagnostics v. Sequenom: Another One Bites The Dust	Schwegman, Lundberg & Woessner, P.A.
Apr 1 2016	Bristol-Myers Squibb v. Merck – Mayo/Alice Rule Reaches Medical Treatment Methods	Schwegman, Lundberg & Woessner, P.A.
Oct 21 2019	Why a Machine Readable Computer Instruction is not Abstract	Schwegman, Lundberg & Woessner, P.A.
Apr 11 2016	Genetic Technologies Affirms Ariosa/Myriad With Introduction By Sequenom Petition for Cert.	Schwegman, Lundberg & Woessner, P.A.
Jan 29 2014	Boiling Down the Logic Behind the CLS Bank Decision	Schwegman, Lundberg & Woessner, P.A.

Subscribe to The 10 Latest Intellectual Property, Patent, Trademark & Copyright News Articles

Trending News